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event involving a network of connected interactions, which still remain fully elusive. Bile acids (BAs) are
ligands of farnesoid X receptor (FXR), a nuclear receptor of ligand-activated transcription factor. FXR has
been shown to be highly involved in liver regeneration. BAs and FXR not only interact with each other
but also regulate various downstream targets independently during liver regeneration. Moreover, recent
ﬁndings suggest that tissue-speciﬁc FXR also contributes to liver regeneration signiﬁcantly. These novel
ﬁndings suggest that FXR has much broader role than regulating BA, cholesterol, lipid and glucose
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The liver is a central organ for homeostasis with unique capacities
of regeneration following loss through trauma or surgical resection
in human body. Liver regeneration has been studied intensively
since the introduction of a rodent partial hepatectomy (PH) model,
in which 2/3 of the liver mass is removed. Unlike anatomic true
regeneration, the expanding liver does not regain its original gross
anatomic structure. Following 2/3 PH, replacement of liver mass is
achieved by proliferation of mature hepatocytes which each
undergoes an average of 1.4 rounds of replication to re-establish
normal liver weight within 5–7 days (8–15 days in humans)1,2.
The process of liver regeneration consists of several well-
orchestrated phases, with rapid induction of proliferative factors
activating the quiescent hepatocytes and priming their subsequent
proliferation, followed by renewed quiescence. Many details of
liver regeneration have been elucidated based on the PH model in
various genetically knockout mice, and several signaling pathways
have been demonstrated in the progress of initiation, promotion
and termination of liver regeneration over these years2,3. Never-
theless, the exact molecular mechanisms from the stimulation of
liver regeneration to the termination of this process remain
incompletely understood.
Farnesoid X receptor (FXR, gene symbol NR1H4/Nr1h4) is a
ligand-activated transcription factor and a member of the nuclear
receptor superfamily, which was initially cloned in 19954,5. FXR
is highly expressed in the liver, intestine, kidney and adrenals. As
a transcription factor, FXR induces the small heterodimer partner
(SHP, gene symbol NR0B2/Nr0b2) in liver that downregulates the
expression of cholesterol 7α-hydroxylase (CYP7A1/Cyp7a1) and
sterol 12α-hydroxylase (CYP8B1/Cyp8b1) genes encoding enzymes
that synthesize bile acids from cholesterol. Thus, FXR is known to
critically regulate nascent bile formation and bile acid (BA) entero-
hepatic circulation. Great progress has been made in the under-
standing of the physiological roles of FXR during the last two
decades. Up to now, FXR has been shown to have crucial roles in
controlling BA homeostasis, lipoprotein and glucose metabolism,
hepatic regeneration, carcinogenesis, intestinal bacterial growth and
the response to hepatotoxins6–8. Recent evidence suggests that the
BAs-FXR interaction is highly involved in the pathophysiology of
hepatic regeneration9.
In the current review, we will discuss the current knowledge of
BAs-FXR interactions in the pathology as well as physiology of
the hepatic regeneration and the proposed underlying mechanisms.2. The role of FXR in liver regeneration
2.1. BA regulates liver regeneration mainly through FXR
BAs are synthesized from cholesterol in hepatocytes, conjugated to
either glycine or taurine and actively secreted via ATP-bindingcassette (ABC) transporters on the canalicular membrane into the
bile. BA synthesis represents a major output pathway of choles-
terol from the body. BAs are detergent molecules and form mixed
micelles with cholesterol and phospholipids, which help to keep
cholesterol in solution in the gall bladder. Eating stimulates the
gall bladder to contract, emptying its contents into the small
intestines. BAs undergo enterohepatic circulation several times
each day, which helps 95% BAs to be reabsorbed from the ileum
and transported back to the liver through the portal vein.
BAs are involved in nascent bile formation, biliary cholesterol
solubilization and intestinal absorption of lipids and lipid-soluble
molecules. Various transport proteins for BAs and the other major
bile lipids (phosphatidylcholine and cholesterol) have been identi-
ﬁed in the liver, which are tightly regulated by nuclear receptors,
such as FXR. Currently, BAs are also increasingly recognized as
signaling molecules in a wide range of ﬁelds, such as energy
homeostasis and metabolism of glucose and lipids. BA-mediated
activation of FXR is a major underlying pathway for these
effects10,11. Moreover, G protein-coupled BA receptor 1
(GPBAR1 or TGR5) has also been identiﬁed recently as liver-
speciﬁc metabolic signals and promotes liver regeneration through
BAs12. It has been demonstrated that, in the hepatobiliary system,
TGR5 is detected in Kupffer cells (KC), biliary epithelium and
sinusoidal endothelial cells, which constitute a permeable barrier
between hepatocytes and blood13. A recent study indicates that
TGR5 is crucial for liver protection against BA overload after PH,
primarily through the control of bile hydrophobicity and cytokine
secretion in the genetic deletion of Tgr5 mouse models. Further
research found that after PH, bile-duct ligation, or upon BA-
enriched feeding, intrahepatic stasis of abnormally hydrophobic
bile may be one of the primary factors involved in liver injury
observed in Tgr5-KO mice12.
BAs are potentially toxic, and substantial increase in hepatic
BA levels will induce hepatocyte death. However, previous studies
indicate that BAs promote normal liver regeneration and repair
after injury. Normal physiological levels of BAs are required for
liver repair10,14. During the early phase after PH, under physiolo-
gical conditions, serum and hepatic BA concentrations tend to
increase, thus leading to the activation of FXR and of other
pathways crucial for hepatocyte protection from BA toxicity. This
would increase the capacity of the liver to manage BA overload
and promote liver regrowth. Huang and co-workers15 showed that
liver regeneration was accelerated in mice in which BA pools
were increased by feeding with a 0.2% cholic acid (CA) diet. In
contrast, decreasing BA pool by feeding with a diet supplemented
with the BA-sequestering resin, cholestyramine, strongly
decreased the rate of liver regeneration. The effects of both CA
and cholestyramine feeding on liver regeneration were absent in
Fxr-knockout (Fxr-KO) mice, suggesting that Fxr is the mediator
of the effect of BA signaling on liver regeneration. Further studies
demonstrate that Fxr-KO mice are unable to handle BA overload
that may elicit detrimental effects including cell death, DNA
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vation, aberrations of the mitotic machinery and cell hyper-
proliferation16. Delayed liver regeneration during the early stage
after PH, and decreased expression of FXR and c-Jun, but
induction of Cyp7a1 mRNA levels were also found in rat models
with the reduction in BA pool size17. Thus, a delicate regulation of
Cyp7a1/CYP7A1 gene expression maybe very important for a
stringent control of BA levels during liver regeneration. During
liver regeneration, hepatic BA levels need to be suppressed rapidly
to prevent the toxic effect of increased BAs in liver, as shown by a
dramatic down-regulation of Cyp7a1 mRNA levels18. Activation
of FXR by either 0.2% cholic acid feeding or oral infusion of an
FXR agonist greatly promoted liver regeneration in sterol 27-
hydroxylase-knockout (Cyp27-KO) mice, which are genetic ani-
mal models with low BA levels19. Patients with BA sequestrant
medications or cerebrotendinous xanthomatosis (CTX) disease due
to Cyp27 gene mutations may have an increased risk of liver
failure, and treatment with FXR ligands can promote liver
regeneration of patients with low BA levels20. These results
suggest that individuals with low BA levels have a higher risk
of liver injury due to their insufﬁciency of liver repair. Thus, FXR
plays a key role in mediating effects of BAs on promoting liver
regeneration.
Besides FXR, the BA membrane transporter, multidrug resis-
tance associated protein 3 (MRP3, gene symbol ABCC3/Abcc3),
has also been investigated in the hepatic growth response elicited
by BA and in liver regeneration after PH. Liver regeneration after
PH was signiﬁcantly delayed in Mrp3-deﬁcient mice. Moreover,
Mrp3-deﬁcient mice showed decreased portal serum levels of BA
and reduced FXR activation in the liver after BA administration21.
These data suggest that MRP3 plays an important role in the
regulation of BA ﬂux during liver regeneration. TGR5 is a G
protein-coupled receptor, from which activation by BA induces
cyclic adenosine monophosphate (cAMP) synthesis22. It is con-
sidered as a crucial regulator of energy homeostasis, as well as a
potential target for the treatment of metabolic syndrome and its
complications, including nonalcoholic steatohepatitis (NASH),
in the context of diabetes and obesity. After PH, severe hepatocyte
necrosis, prolonged cholestasis, exacerbated inﬂammatory response,
and delayed regeneration were observed in Tgr5-KO mice. The lack
of Tgr5 led to more hydrophobic bile and excessive hepatic
inﬂammation after PH, which were associated with deﬁcient
adaptation of bile composition and ﬂow, and insufﬁcient BA efﬂux
in urine. All these factors contributed to excessive BA overload,
which induced liver injury and delayed regeneration. Further
research showed that in the absence of Tgr5, early post-PH liver
injury was not affected by KC depletion. Thus, inﬂammation
appears more as a worsening, rather than a triggering, factor in
the Tgr5-KO mice after PH12.
In conclusion, a relative high level of BAs is important for the
initiation of hepatic regeneration. Moreover, the BA-mediated
siginaling pathways are parts of the molecular mechanisms
affecting liver regeneration, which need to be further investigated.2.2. FXR regulates pathways independent of BAs in the process
of liver regeneration
As mentioned, FXR promotes liver regeneration after PH or liver
injury. The FXR transcriptional activity in control of BA levels
and other signaling pathways is crucial for hepatocyte protection
and cell proliferation during heptic regeneration. Monte andcolleagues23 studied the changes in the expression patterns of
genes involved in BA synthesis during rat liver regeneration after
2/3 PH. The Fxr mRNA levels were ﬁrst reduced (day 1–2) and
then (day 3) increased. However, the Shp mRNA levels were also
transiently enhanced at an earlier time point than those of Fxr (day
2). As a pleiotropic regulator, SHP modulates the expression of
multiple target genes involved in diverse biological processes,
including regulation of metabolic pathways, stress and inﬂamma-
tory response, detoxiﬁcation, cellular adhesion and differentiation,
and cell cycle control24. Thus, activation of SHP may regulate the
downstream apoptosis pathways in hepatocytes after PH.
The thyroid hormone (TH) plays a signiﬁcant role in diverse
processes related to growth, development, differentiation, and
metabolism. At the cellular level, the TH exerts its effects after
concerted mechanisms to facilitate binding to the TH receptor
(THR)25. Although THs and their receptors are not required for
liver regeneration, mice lacking Thrα1/Thrβ or Thrβ alone showed
delayed commitment to the initial round of hepatocyte prolifera-
tion26. Moreover, the remaining hepatocytes in the mouse livers
were found transient but intense apoptosis at 48 h after PH, which
may be due to the induction of FXR to upregulate the activity of
dimethylarginineaminohydrolase-1 (DDAH-1) in the regenerating
liver26.
FXR is the primary sensor of BAs, and both conjugated and
unconjugated BAs can activate FXR at physiological concentra-
tions. One of the primary BAs, chenodeoxycholic acid (CDCA) is a
potent endogenous activator of FXR. Diets enriched with CDCA
increase the liver/body weight ratios by 50% due to hepatocellular
hypertrophy in wild type (WT) but not Fxr-KO mice. Further
research demonstrated that hematopoietically expressed homeobox
(HEX), a central transcription factor in vertebrate embryogenesis
and liver development, is the BA-induced FXR target gene during
adaptation of hepatocytes to chronic BA exposure27. CCAAT-
enhancer binding protein (C/EBPβ) is a key transcription factor
which is necessary for the expression of genes involved in
maintaining normal liver physiology. Recent study demonstrated
that CDCA induces antioxidant and xenobiotic-metabolizing
enzymes by activating C/EBPβ through phosphorylation. Further
research revealed that CDCA treatment activated AMP-activated
protein kinase (AMPK), which led to extracellular signal-regulated
kinase 1/2 (ERK1/2) activation, through the activation of FXR.
Moreover, enforced expression of FXR promoted the phosphory-
lation of AMPKα, ERK1/2, and C/EBPβ, verifying that C/EBPβ
phosphorylation elicited by CDCA results from the activation of
AMPK and ERK1/2 by FXR. Thus, the mechanism of C/EBPβ
activation by CDCA is regulated by FXR through the AMPK-
ERK1/2 pathway. Therefore, activation of C/EBPβ by CDCA may
be necessary for the induction of detoxifying enzymes during liver
injury28. To study the mechanism that terminate liver regeneration,
Timchenko's group29 generated C/EBPα-S193A knockin mice,
which have decreased the phosphorylation of S193A in formation
of complexes of C/EBP family proteins. They found that, livers of
C/EBPα-S193A mice fail to stop liver regeneration after surgery
when livers reach the original pre-resection size. Further research
showed C/EBPβ-HDAC1 complexes repress Sirt1, Pgc1α, Fxr,
p53 and Tert gene expression in livers of S193A mice, which may
be responsible for the failure of terminating liver regeneration.
These results showed that activation of FXR may be one of the
termination pathways in the late stage of hepatic regeneration.
Forkhead box m1b (FOXM1b) is a proliferation-speciﬁc
member of the forkhead box family of transcription factors that
is ubiquitously expressed in embryonic tissues and cultured cells.
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tocyte proliferation by regulating the expression of cell cycle genes
that stimulate cyclin-dependent kinase 2 and cyclin-dependent
kinase 1 activity, is essential for hepatocyte entry into mitosis
during liver development, regeneration, and carcinogenesis30–32.
FOXM1b transcription factor is required for normal liver rege-
neration. The rate of liver growth was much slower in the early
stages of liver regeneration in Fxr-KO mice. Activation of FXR by
BAs increased the expression of FOXM1b, which was shown to
regulate cell cycle progression during liver regeneration33. Huang's
group34 further found that Foxm1b is a direct FXR target gene
involved in cell cycle regulation. They also demonstrated that
defective activation of FXR, which results in inhibition of
Foxm1b, is an intrinsic defect in aging regenerating livers. More-
over, activation of FXR is able to alleviate age-related liver
regeneration defects14,15,35. These ﬁndings highlight FXR as a
potential target of drug design for promoting liver regeneration in
older subjects. Other studies in rodents suggest that FXR agonists
may improve liver metabolic functions, prevent cell death and
promote hepatocyte proliferation thus highlighting the potential
use of FXR agonists in conditions such as pathological suppres-
sion of liver regrowth, liver failure, or after hepatectomy/liver
transplantation. In summary, FXR plays an important role in the
whole process of liver regeneration through regulation of various
signaling pathways.2.3. Intestinal FXR in the regulation of liver regeneration
The BA enterohepatic circulation and the process of bile formation
are tightly regulated, depending on modulating dietary and
hormonal signals. The importance of BA-mediated, FXR-
dependent pathways for liver regeneration emerged from the
observation that external biliary drainage and biliary obstruction,
which interrupt BA enterohepatic circulation and delay liver
regeneration36. Whole body deletion of Fxr results in signiﬁcant
inhibition of liver regeneration after PH. Since FXR gene is highly
expressed in the liver and intestine, both hepatic- and intestine-
FXR are involved in the regulation of BA homeostasis14. More-
over, recent reports indicate that FXR regulates a distinct set of
genes in a tissue-speciﬁc manner37,38. Recent studies using tissue-
speciﬁc Fxr-KO mice showed that both liver- and intestine-speciﬁc
Fxr-KO mice exhibit impaired regeneration in response to resec-
tion- and toxin-induced regenerative stimuli38,39.
Liver regeneration after PH in hepatocyte-speciﬁc Fxr-KO
(hepFxr-KO) mice was studied over a time course of 0–14 days.
Although the overall kinetics of liver regrowth in hepFxr-KO mice
was not affected, a delay in peak hepatocyte proliferation from day
2 to day 3 after PH was observed in hepFxr-KO mice compared
with the control mice39. Further studies revealed decreased Cyclin
D1 gene expression and decreased association of cyclin D1 with
CDK4 in hepFxr-KO mice after PH were correlated with
decreased phosphorylation of the retinoblastoma (Rb) protein
and delayed cell proliferation in the hepFxr-KO livers. Moreover,
a signiﬁcant delay in hepatocyte growth factor-initiated signaling,
including the AKT, c-Myc and ERK1/2 pathways, was observed
in hepFxr-KO mice39. These data indicate that regulation of liver
regeneration after PH by FXR is likely dependent on the gut-liver
FXR signaling axis and not on the hepatic FXR alone. These
studies highlight the complex multipathway signaling involved in
regulation of liver regeneration after PH, and suggest a strong rolefor metabolic signals in the initiation and termination of liver
regeneration.
Intestinal FXR affects BA homeostasis in mice by inducing
intestinal epithelial expression of ﬁbroblast growth factor 15
(FGF15) in mice and FGF19 in humans, which is transported
via portal circulation to the liver, where it suppresses BA
synthesis40. Consistently, several reports also suggest that
FGF15 secreted from ileum has profound effects on liver
metabolism as well as regeneration41,42. Interestingly, Fgf15-KO
mice were recently reported to exhibit both impaired resection-
induced hepatic regeneration and reduce enteral BA-stimulated
hepatomegaly43. Therefore, FGF15 induction after liver damage
may also contribute to the normal liver regeneration. Previously
studies showed that the suppression of CYP7A1 expression and
decreased BA synthesis was beneﬁcial for liver regeneration15.
Huang's group also found that, during liver regeneration/repair,
activation of FXR induces the expression of FGF15 in the intestine
to suppress Cyp7a1 transcription. Thus, induction of FGF15 after
liver damage may also contribute to normal liver regeneration
through enterohepatic circulation. Recently, we found that Fgf15-
KO mice following 2/3 PH displayed extensive liver necrosis, and
marked elevation of serum BAs and bilirubin compared with WT
mice. Furthermore, hepatocyte proliferation was reduced in the
Fgf15-KO mice due to impaired cell cycle progression which is
important for liver regeneration. Less activation of signal transdu-
cer and activator of transcription 3 (STAT3), NF-ĸB, and mitogen-
activated protein kinase (MAPK) is also shown in the Fgf15-KO
mice compared with WT mice after 2/3 PH. Meanwhile, a
reduction with/without delayed induction of immediate-early
response genes, including growth-control transcription factors,
was found at early time points after PH in livers of the Fgf15-KO
mice44. Therefore, activation of FXR in the intestine can induce
FGF15 protein, which could repress Cyp7a1 gene transcription by
the activation of c-Jun N-terminal kinase (JNK)/ERK pathways in
the liver through its receptor FGF receptor 4 (FGFR4). Lack of
FGF15 feedback suppression by Fgf15 deletion leads to increased
BA biosynthesis. The accumulation of BAs would further cause
toxicity and damage to hepatocytes. In addition to feedback
regulation of Cyp7a1 transcription, reduced JNK/ERK activation
could deactivate STAT3/NF-ĸB signaling pathways, which are
crucial for the priming phase of liver regeneration. In conclusion,
FGF15 is necessary to maintain BA homeostasis and prevent
liver injury during liver regeneration. Moreover, FGF15 is an
essential mediator of the liver growth-promoting effects of BAs.
Preoperative administration of this enterokine to patients under-
going liver resection might be useful to reduce damage and foster
regeneration.
In summary, intestine FXR can activate FGF15 expression in
the intestine to promote liver regeneration. Therefore, in addition
to the cell-autonomous and hepatic regenerative effects of hepatic
FXR, the endocrine FGF15 pathway induced by intestine FXR
also participates in the promotion of liver regeneration. Thus,
hepatic and intestine FXR, FGF15, and enterohepatic circulation
of bile acids are the fundamental frames in the metabolic regulation
of liver regeneration system.3. Conclusions and perspectives
Normal liver regeneration is important for restoring the liver mass
following liver injury. The function of FXR has been expanded
from regulating BA homeostasis to mediating lipid and glucose
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of FXR by elevated BA levels accelerates liver regeneration,
whereas decreased BA levels and absence of FXR/Fxr inhibit liver
growth. Of note is that although the absence of FXR/Fxr inhibits
liver growth, Fxr-KO mice spontaneously develop liver tumors as
they age, asserting that BA-induced DNA damage in Fxr-KO mice
may be critical in liver tumor development even if FXR/Fxr
absence limits liver regeneration45. The novel roles of FXR in
promoting liver regeneration and protecting against hepatocarci-
nogenesis, however, are consistent with its previously deﬁned
functions in regulating BA metabolism and defending against BA
toxicity. TGR5, which is one of the new BA receptors, is needed
to be further studied to understand the underlying mechanism of
liver regeneration. Moreover, further work should be done to
reveal the role of FGF15, the key regulator of BA enterohepatic
circulation, in the process of heptic regeneration. Therefore,
increased understanding of the hepatic regenerative process will
be signiﬁcant beneﬁt in the treatment of liver failure. Furthermore,
understanding of liver regeneration may shed light on the
development of hepatocellular cancer. In addition, given the
rapidly increasing demand of liver transplantation, targeting FXR
pharmacologically may provide a novel approach to accelerate
liver regeneration after liver transplantation or surgery.
In summary, elucidating the molecular mechanisms of liver
regeneration by FXR and BAs could lead to life-saving therapy for
a large number of patients, especially elderly patients, after
segmental liver transplantation or resection of liver tumors.
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